Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,468
  • Shares Outstanding, K 18,285
  • Annual Sales, $ 0 K
  • Annual Income, $ -20,300 K
  • 60-Month Beta 1.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCTX with:

Options Overview Details

View History
  • Implied Volatility 263.02% ( +10.48%)
  • Historical Volatility 106.07%
  • IV Percentile 88%
  • IV Rank 56.88%
  • IV High 438.74% on 04/12/24
  • IV Low 31.24% on 07/18/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 10,819
  • Open Int (30-Day) 11,098

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/24
See More
  • Average Estimate -0.46
  • Number of Estimates 1
  • High Estimate -0.46
  • Low Estimate -0.46
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -206.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9500 +6.32%
on 06/25/24
1.7500 -42.29%
on 06/03/24
-0.6800 (-40.24%)
since 05/31/24
3-Month
0.9500 +6.32%
on 06/25/24
3.0300 -66.67%
on 04/04/24
-1.7400 (-63.27%)
since 04/02/24
52-Week
0.9500 +6.32%
on 06/25/24
7.5900 -86.69%
on 08/28/23
-5.4100 (-84.27%)
since 06/30/23

Most Recent Stories

More News
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 13, 2023 – USA News Group  –  Sufferers of many different ailments saw reason to grow their hope in 2022 when...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
FULC : 6.10 (-3.33%)
RNA : 38.80 (-6.01%)
BCTX : 1.0100 (-7.34%)
BCT.TO : 1.36 (-11.11%)
GILD : 68.40 (-0.35%)
Stocks in play: BriaCell Therapeutics Corp.

Announced that it has received approval from FDA on its pivotal registrational study design for Bria-IMTâ„¢ ...

BCTX : 1.0100 (-7.34%)
Five Top Companies Fighting for the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...

LLY : 906.71 (-0.84%)
PBYI : 3.10 (-5.49%)
GILD : 68.40 (-0.35%)
IMGN : 31.23 (unch)
BCTX : 1.0100 (-7.34%)
BCT.TO : 1.36 (-11.11%)
There are Positive Developments in the Treatment of Metastatic Breast Cancer

A significant medical breakthrough is desperately needed in the fight against metastatic breast cancer. As it stands right now, metastatic breast cancer has no cure and has proven resistant to many cancer...

LLY : 906.71 (-0.84%)
PBYI : 3.10 (-5.49%)
GILD : 68.40 (-0.35%)
IMGN : 31.23 (unch)
BCTX : 1.0100 (-7.34%)
BCT.TO : 1.36 (-11.11%)
Five Impressive Metastatic Cancer Treatment Stocks to Own Today

A significant medical breakthrough is desperately needed in the fight against breast cancer. At the moment, according to the American Cancer Society, more than 3.1 million women in the United States alone...

LLY : 906.71 (-0.84%)
PBYI : 3.10 (-5.49%)
GILD : 68.40 (-0.35%)
IMGN : 31.23 (unch)
BCTX : 1.0100 (-7.34%)
BCT.TO : 1.36 (-11.11%)
Positive Developments for Breast Cancer Care Attracting Big Investor Attention

A significant medical breakthrough is sorely needed in the fight against breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of invasive...

BCTX : 1.0100 (-7.34%)
PFE : 27.83 (-1.38%)
GILD : 68.40 (-0.35%)
PBYI : 3.10 (-5.49%)
MRK : 127.72 (-0.14%)
BCT.TO : 1.36 (-11.11%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 1.0100 (-7.34%)
ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
CTMX : 1.3200 (-0.75%)
BCT.TO : 1.36 (-11.11%)
RLAY : 6.47 (+1.09%)
HOLX : 73.53 (-0.77%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

/PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in...

BCTXW : 0.2400 (-10.75%)
ONC.TO : 1.37 (+1.48%)
BCT.TO : 1.36 (-11.11%)
ONCY : 0.9900 (-0.52%)
CTMX : 1.3200 (-0.75%)
BCTX : 1.0100 (-7.34%)
RLAY : 6.47 (+1.09%)
HOLX : 73.53 (-0.77%)
FDA’s Wave of Fast Track Designations Pushing Momentum in Healthcare Sector in 2023

USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food and Drug Administration (FDA) granted several approvals and new Fast Track designations towards...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
RHHBY : 34.4300 (-0.61%)
FULC : 6.10 (-3.33%)
RNA : 38.80 (-6.01%)
BCTX : 1.0100 (-7.34%)
BCT.TO : 1.36 (-11.11%)
GILD : 68.40 (-0.35%)
Breast Cancer Treatment Options Evolved Over the Last 12 Months, Bringing More Hope for 2023

USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in nature and giving hope to families dealing with a fateful...

BCTX : 1.0100 (-7.34%)
ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
CTMX : 1.3200 (-0.75%)
BCT.TO : 1.36 (-11.11%)
RLAY : 6.47 (+1.09%)
HOLX : 73.53 (-0.77%)

Business Summary

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 1.2067
2nd Resistance Point 1.1633
1st Resistance Point 1.0867
Last Price 1.0100
1st Support Level 0.9667
2nd Support Level 0.9233
3rd Support Level 0.8467

See More

52-Week High 7.5900
Fibonacci 61.8% 5.0535
Fibonacci 50% 4.2700
Fibonacci 38.2% 3.4865
Last Price 1.0100
52-Week Low 0.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar